Allogene Therapeutics, Inc.

NasdaqGS:ALLO Stock Report

Market Cap: US$486.5m

Allogene Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:ALLO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 May 24SellUS$26,181Franz HumerIndividual11,200US$2.34
16 May 24BuyUS$4,999,997Vida Ventures Advisors, LLCCompany1,724,137US$2.90
30 Jan 24BuyUS$683Geoffrey ParkerIndividual190US$3.60
07 Aug 23SellUS$42,855Stephen MayoIndividual10,000US$4.29

Insider Trading Volume

Insider Buying: ALLO insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of ALLO?
Owner TypeNumber of SharesOwnership Percentage
Private Companies6,0720.00291%
Individual Insiders15,816,8257.58%
VC/PE Firms18,716,3068.96%
Public Companies22,032,04010.6%
General Public35,551,95717%
Institutions116,661,21455.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 43.2%.


Top Shareholders

Top 25 shareholders own 72.93% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.2%
FMR LLC
25,363,798US$59.1m0.48%no data
10.6%
Pfizer Inc.
22,032,040US$51.3m0%no data
8.96%
TPG Capital, L.P.
18,716,306US$43.6m0%0.15%
4.62%
BlackRock, Inc.
9,652,930US$22.5m-3.49%no data
4.4%
State Street Global Advisors, Inc.
9,184,011US$21.4m278%no data
3.93%
The Vanguard Group, Inc.
8,207,564US$19.1m-9.12%no data
3.7%
David Chang
7,723,302US$18.0m47.8%no data
2.94%
Arie Belldegrun
6,129,941US$14.3m14.8%no data
2.61%
PRIMECAP Management Company
5,448,386US$12.7m3.15%0.01%
2.38%
JP Morgan Asset Management
4,960,916US$11.6m-25.1%no data
2%
T. Rowe Price Group, Inc.
4,177,619US$9.7m76.2%no data
1.84%
Tavistock Life Sciences
3,850,000US$9.0m0%0.51%
1.69%
Vida Ventures Advisors, LLC
3,522,300US$8.2m95.9%6.4%
1.49%
Citadel Advisors LLC
3,113,225US$7.3m-23.2%0.01%
1.37%
Frazier Life Sciences Management, LP
2,867,750US$6.7m0%0.33%
1.26%
Woodline Partners LP
2,633,976US$6.1m2.19%0.06%
1.14%
Geode Capital Management, LLC
2,371,334US$5.5m1.55%no data
0.98%
Dimensional Fund Advisors LP
2,043,619US$4.8m33.1%no data
0.92%
Wildcat Capital Management, LLC
1,920,787US$4.5m0%1.04%
0.92%
Two Sigma Investments, LP
1,911,338US$4.5m-17.4%0.01%
0.86%
Morgan Stanley, Investment Banking and Brokerage Investments
1,788,930US$4.2m40.7%no data
0.65%
Vestal Point Capital, LP
1,350,000US$3.1m0%0.29%
0.64%
Two Sigma Advisers, LP
1,331,100US$3.1m4.18%0.01%
0.47%
Rafferty Asset Management, LLC
990,703US$2.3m333%0.01%
0.47%
Northern Trust Global Investments
971,067US$2.3m-4.27%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.